Cardiff Oncology, Inc.·4

Jul 16, 4:03 PM ET

PACE GARY W 4

4 · Cardiff Oncology, Inc. · Filed Jul 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Cardiff Oncology Director Gary Pace Buys $1.0M of Stock

What Happened
Director Gary W. Pace made a purchase on July 14, 2026: he acquired 687,285 common shares of Cardiff Oncology (CRDF) at $1.46 per share for a total cash outlay of $1,000,000. The filing also shows an acquisition of 687,285 derivative securities (common warrants) at $0 consideration that are tied to the same share amount.

Key Details

  • Transaction date: 2026-07-14; Form 4 filed: 2026-07-16 (timely, within standard 2 business days).
  • Cash purchase: 687,285 shares @ $1.46 = $1,000,000.
  • Derivative acquisition: 687,285 warrants (acquired at $0.00 consideration).
  • Footnotes: F1 — warrants become exercisable on the later of (i) six months after issuance or (ii) the date the company increases authorized shares and stockholder approval is obtained; F2 — exercise term is 5.5 years after that Initial Exercise Date.
  • Shares owned after the transaction are not specified in the provided excerpt.

Context
Purchases by insiders can be viewed as more informative than sales since they represent a cash commitment; this filing shows both an outright share purchase and receipt of time-locked warrants. The warrants cannot be exercised immediately — they have a delayed exercisability condition and a multi-year exercise window once exercisable. This summary is factual only and does not infer the insider’s motives.

Insider Transaction Report

Form 4
Period: 2026-07-14
PACE GARY W
Director
Transactions
  • Purchase

    Common Stock

    2026-07-14$1.46/sh+687,285$1,000,0002,043,661 total
  • Purchase

    Common Stock Purchase Warrant

    [F1][F2]
    2026-07-14+687,285687,285 total
    Exercise: $1.33Common Stock (687,285 underlying)
Footnotes (2)
  • [F1]Exercisable beginning on the later of (i) six months after issuance or (ii) the Authorized Share Increase Date (the "Initial Exercise Date"). "Authorized Share Increase Date" means the date on which an amendment to the Issuer's certificate of incorporation increasing the number of authorized shares of its common stock to an amount sufficient for the exercise in full of the Common Warrants is filed with and accepted by the State of Delaware, subject to approval of such amendment by its stockholders.
  • [F2]The term of exercise is equal to five and one-half years after the Initial Exercise Date.
Signature
/s/ Gary Pace|2026-07-16

Documents

1 file
  • 4
    ownership.xmlPrimary

    4